Trial
NCT04860635
Safety of F14 Following Total Knee Replacement
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Arthritis Innovation Corporation
Collaborators
—
Condition
Analgesia
Intervention
F14 (sustained release celecoxib)
Why stopped
Study superseded by alternative Phase 3 trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-05